US medtech industry report shows 510(k) process is "remarkably safe"
This article was originally published in Clinica
Executive Summary
US medtech industry association AdvaMed has issued a report highlighting "the remarkable safety record" of the controversial pre-market notification or 510(k) process that is used by the Food and Drug Administration for clearing most low- and moderate-risk devices1,2.